File Download

There are no files associated with this item.

Supplementary

Conference Paper: Beneficial effects of EPS on human health and gut microbiota

TitleBeneficial effects of EPS on human health and gut microbiota
Authors
KeywordsProbiotics
Exopolysaccharide
Bioactivity
Issue Date2015
Citation
The 2015 ADSA-ASAS Joint Annual Meeting, Orlando, FL., 12-16 July 2015. How to Cite?
AbstractRecently bacterial exopolysaccharide (EPS) extracted from Lactobacillus spp. and Bifidobacterium spp. has received considerable attention, mainly due to the novel and unique physical characteristics and physiological functions. EPS contributes to biofilm formation and host healthy maintenance, it can be used as an instrument for probiotics to survive in harsh condition. In this review, we provide a fresh perspective and focus on the advancement of bioactivity and immune modulating capability of exopolysaccharide. Indeed, EPS from Lactobacillus spp. and Bifidobacterium spp. exhibit many beneficial bioactivity including anti-tumor activity, antiviral activity, radical scavenging activity and abrogate the cytotoxic effect. Therefore, it has great potential for further development as therapeutic agents or adjuvants for cancer. Furthermore, EPS binds to common surface receptors to elicit the immune response in host, it was able to reduce the secretion of the proinflammatory e.g., IL-6. Thus, the EPS seem to be critical in studying the physiology of Lactobacillus spp. and Bifidobacterium spp. and their interaction with the host.
DescriptionOral Session: Dairy Foods Symposium: Advances in bacterial exopolysaccharides - From production to applications in dairy foods and health: abstarct no. 664
Persistent Identifierhttp://hdl.handle.net/10722/220697

 

DC FieldValueLanguage
dc.contributor.authorWei, H-
dc.contributor.authorZhang, Z-
dc.contributor.authorTao, X-
dc.contributor.authorFeng, X-
dc.contributor.authorXu, H-
dc.contributor.authorWan, C-
dc.contributor.authorWu, Q-
dc.contributor.authorShah, NP-
dc.date.accessioned2015-10-16T06:49:53Z-
dc.date.available2015-10-16T06:49:53Z-
dc.date.issued2015-
dc.identifier.citationThe 2015 ADSA-ASAS Joint Annual Meeting, Orlando, FL., 12-16 July 2015.-
dc.identifier.urihttp://hdl.handle.net/10722/220697-
dc.descriptionOral Session: Dairy Foods Symposium: Advances in bacterial exopolysaccharides - From production to applications in dairy foods and health: abstarct no. 664-
dc.description.abstractRecently bacterial exopolysaccharide (EPS) extracted from Lactobacillus spp. and Bifidobacterium spp. has received considerable attention, mainly due to the novel and unique physical characteristics and physiological functions. EPS contributes to biofilm formation and host healthy maintenance, it can be used as an instrument for probiotics to survive in harsh condition. In this review, we provide a fresh perspective and focus on the advancement of bioactivity and immune modulating capability of exopolysaccharide. Indeed, EPS from Lactobacillus spp. and Bifidobacterium spp. exhibit many beneficial bioactivity including anti-tumor activity, antiviral activity, radical scavenging activity and abrogate the cytotoxic effect. Therefore, it has great potential for further development as therapeutic agents or adjuvants for cancer. Furthermore, EPS binds to common surface receptors to elicit the immune response in host, it was able to reduce the secretion of the proinflammatory e.g., IL-6. Thus, the EPS seem to be critical in studying the physiology of Lactobacillus spp. and Bifidobacterium spp. and their interaction with the host.-
dc.languageeng-
dc.relation.ispartofADSA-ASAS Joint Annual Meeting-
dc.subjectProbiotics-
dc.subjectExopolysaccharide-
dc.subjectBioactivity-
dc.titleBeneficial effects of EPS on human health and gut microbiota-
dc.typeConference_Paper-
dc.identifier.emailShah, NP: npshah@hku.hk-
dc.identifier.authorityShah, NP=rp01571-
dc.identifier.hkuros255721-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats